Type I and II Endometrial Cancers: Have They Different Risk Factors?Veronica Wendy Setiawan, Jennifer A. Doherty, Amanda B. Spurdle et al.|Journal of Clinical Oncology|2013Cited by 833
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Marcus Q. Bernardini, Martin Köbel et al.|The Lancet Oncology|2013Cited by 434
Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot”Sharon E. Johnatty, Catherine M. Phelan, Jonathan Beesley et al.|PLoS Genetics|2010Cited by 68
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome AtlasSharon E. Johnatty, Georgia Chenevix‐Trench, Jonathan Beesley et al.|Gynecologic Oncology|2013Cited by 63
Germline polymorphisms in an enhancer of <i>PSIP1</i> are associated with progression-free survival in epithelial ovarian cancerJuliet D. French, Allan Jensen, Sharon E. Johnatty et al.|Oncotarget|2016Cited by 36